Electric field treatment for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new device that uses pulsed electric fields to destroy prostate cancer cells while healthy tissue is spared. It may help men with different stages of prostate cancer, and the study will see how safe and effective it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 45 or older, and your doctor expects you to live at least 10 more years.
- You have been diagnosed with prostate cancer that is low, intermediate, or high risk based on PSA levels, Gleason score, and tumor stage.
- You have not had any prior treatment for prostate cancer (like surgery, radiation, or hormone therapy) or radiation to the pelvis.
- Your cancer has not spread to lymph nodes or other organs outside the prostate.
- You are able to have an MRI and anesthesia, meaning no severe claustrophobia or other reasons that would make these unsafe.
- If you have an unfavorable intermediate or high-risk cancer, you must be willing to have prostate removal surgery (prostatectomy) 1 to 6 months after the study treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a type of focused radiation (“ablative radiotherapy”) for prostate tumors considered intermediate- or high-risk. It may help improve control of the cancer while aiming for acceptable side effects.
This trial tests a laser treatment to destroy cancer cells in the prostate for people with early-stage prostate cancer who choose not to have surgery. It aims to target only the cancer while sparing healthy tissue.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This study tests a new, less invasive treatment using targeted microwave ablation (TMA) to destroy prostate cancer tumors. It is designed for men with early-stage, low to intermediate-risk prostate cancer that hasn't spread, offering a possible alternative to surgery or radiation.
This trial tests a treatment that uses high-intensity focused ultrasound to target and destroy cancer cells in the prostate, combined with a newer hormone therapy. This approach may help control advanced prostate cancer and improve outcomes.
This study collects information from men with prostate cancer who are having or have had a procedure to destroy prostate tumors (ablation). It aims to track outcomes over time to improve future treatments.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.